{
    "clinical_study": {
        "@rank": "112866", 
        "brief_summary": {
            "textblock": "To develop a clinical severity index that could prospectively identify sickle cell disease\n      patients who were at high risk for a turbulent clinical course and a poor prognosis."
        }, 
        "brief_title": "Indices of Severity and Prognosis for Sickle Cell Disease", 
        "completion_date": "December 1992", 
        "condition": [
            "Anemia, Sickle Cell", 
            "Blood Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Anemia, Sickle Cell", 
                "Hematologic Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "DESIGN NARRATIVE:\n\n      Using the database, univariate analysis showed that factors associated with the occurrence\n      of cerebrovascular accident (51 patients) included hematocrit, rate of change of pocked red\n      cell count, and polymer fraction at 40 percent oxygen saturation (PF40).  Only low\n      hematocrit was predictive of death in the pediatric cohort.  There were 45 disease-related\n      deaths."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "No eligibility criteria"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "May 25, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00005467", 
            "org_study_id": "4912"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": {
            "PMID": "8311173", 
            "citation": "Bray GL, Muenz L, Makris N, Lessin LS. Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study. Am J Pediatr Hematol Oncol. 1994 Feb;16(1):50-4."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00005467"
        }, 
        "source": "National Heart, Lung, and Blood Institute (NHLBI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "January 1990", 
        "study_design": "Observational Model: Natural History", 
        "study_type": "Observational", 
        "verification_date": "May 2000"
    }, 
    "geocoordinates": {}
}